Zepbound 10 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F1T46
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $57,501
Award facts
- Contract value 100% obligated
- $57,501.45 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $57.5K delivery order to AmerisourceBergen Drug Corp on January 7, 2026, for the supply of Zepbound 10 mg/0.5 mL pens (semaglutide injection), a GLP-1 receptor agonist indicated for weight management. The award, which carries a firm fixed-price structure with no set-aside designation, is expected to be completed by January 8, 2026, and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $1B through December 31, 2031, which serves as the primary vehicle for supplying comprehensive pharmaceutical and medical commodities to support military healthcare programs globally.
AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, holds a critical position within the federal medical supply chain as a preferred vendor for the Department of Defense. The company's extensive portfolio of federal contracts demonstrates its capability to deliver diverse pharmaceutical products across multiple therapeutic domains to military treatment facilities and other government healthcare systems. This particular order for Zepbound reflects the Department of Defense's procurement of specialty medications for beneficiary healthcare needs, consistent with the company's established role as a key supplier of brand-name and generic medications to support military personnel and veteran populations.
Quick answers
Who was awarded contract SPE2DR26F1T46?
SPE2DR26F1T46 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26F1T46 worth?
The government has obligated $57,501 on SPE2DR26F1T46.
Is contract SPE2DR26F1T46 an order under another contract?
Yes. SPE2DR26F1T46 is a delivery order under SPE2DR25D2205, an indefinite delivery contract.
Was contract SPE2DR26F1T46 competed?
The extent of competition for SPE2DR26F1T46 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award